Boothbay Fund Management’s Cerevel Therapeutics Holdings, Inc. Warrant CEREW Stock Holding History

Boothbay Fund Management’s Portfolio CEREW Stock Details CEREW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-12,032	Closed	-$308K	–	2404
2021 Q2	$308K	Hold	12,032	–	–	0.01%	1263
2021 Q1	$165K	Sell	12,032 -63,368	-84%	-$287K	0.01%	1399
2020 Q4	$1.25M	Buy	+75,400	New	+$304K	0.05%	420

Boothbay Fund Management's CEREW Position: Q3 2021 in Review

Boothbay Fund Management sold out of Cerevel Therapeutics Holdings, Inc. Warrant (CEREW) in Q3 2021, closing a stake of 12,032 shares — an estimated $308K sold.

Boothbay Fund Management first reported a position in CEREW in Q4 2020 and held it in 3 quarters. The position peaked at $1.25M in Q4 2020. 0 funds tracked by Wall St. Rank hold CEREW as of Q3 2021.

Boothbay Fund Management reported no remaining Cerevel Therapeutics Holdings, Inc. Warrant position as of Q3 2021 after selling out during the quarter.
Boothbay Fund Management sold 12,032 Cerevel Therapeutics Holdings, Inc. Warrant shares in Q3 2021, an estimated $308K.
Boothbay Fund Management first reported a position in Cerevel Therapeutics Holdings, Inc. Warrant in Q4 2020 and held it in 3 quarters.
Boothbay Fund Management's Cerevel Therapeutics Holdings, Inc. Warrant position peaked at $1.25M in Q4 2020.
0 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Warrant as of Q3 2021.

Based on Boothbay Fund Management's 13F filing for Q3 2021, filed 15 Nov 2021.